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CASE REPORT
A 31-year-old male patient, with the history of 
HIV infection diagnosed 16 years ago, sought medical 
care complaining of high-grade fever, diaphoresis, 
and cough with few whitish sputum during the last 
20 days. He referred 20 kg of weight loss during the 
last 8 months associated with intermittent epigastric 
pain and dysphagia. He deliberately withdrew the 
HAART regimen and the medical follow-up during the 
last three years. After hospitalization, he was initially 
treated with antibiotics, with favorable outcome, 
but still referred worsening of the epigastric pain 
and dysphagia. Initial laboratory work up revealed a 
normal total blood cell count, as well as renal and liver 
function tests, electrolytes and lactate dehydrogenase. 
CD4 cell count was 261 cells/mm3 and viral load 
was 163,597 copies/mL. The upper gastrointestinal 
endoscopy showed a 20 cm-length narrowing of 
distal esophagus, recovered by a healing pattern 
mucosa. At the posterior wall of the antrum an ulcer 
measuring 4 cm at its longest axis, with elevated and 
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ABSTRACT
HIV infection is known to be associated with the development of a wide range of neoplasia. About 25 to 40% of HIV-
positive patients will present some kind of malignancy in the course of the disease; among them 10% are non-Hodgkin 
lymphomas (NHL) and 20% of these are represented by the diffuse large B-cell lymphoma. HIV-positive patients have a 
relative risk of 110 times higher to develop neoplasia, than the non-infected population. The gastrointestinal (GI) tract 
is the most frequent extranodal site of involvement. However, the primary GI lymphoma is rare. The authors present a 
case of a 31-year-old male patient with a 16-year history of HIV infection, who deliberately withdrew the Highly Active 
Antiretroviral Therapy (HAART) regimen and was hospitalized because of a respiratory infection. Because of a long-term 
complaint of dyspepsia, an upper gastrointestinal endoscopy was performed disclosing a large elevated and ulcerated 
gastric lesion, which biopsy revealed a diffuse large B-cell lymphoma. Clinical, imaging and laboratory tests showed an 
early stage diagnosis: Lugano stage I. Although not frequent, the authors alert to considering this neoplasia in all HIV-
positive patients with dyspeptic symptoms.
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well-circumscribed borders and clean wound bed was 
found (Figure 1).
Biopsies were performed from the esophageal 
and gastric lesions. Pathologic examination of the 
esophagus revealed unspecific chronic esophagitis 
with Candida sp. Gastric biopsies revealed a high-
grade, poorly-differentiated neoplasia, with atypical 
poorly cohesive cells in a solid pattern, mitotic figures 
and conspicuous nucleoli. Helicobacter pylori was 
not detected (Giemsa stain). Immunohistochemistry 
showed diffuse and strong staining for CD20+ and 
Bcl-6; and negative staining for CD30 and MUM-1. 
Proliferation index was 80-90% as accessed by Ki67. 
Immunostainings for keratins (AE1-AE3), Epstein-Barr 
virus (EBV), Bcl-2 and cyclin-D1 were negative. In situ 
hybridization for EBV was negative. The morphology 
accompanied by the immunohistochemical panel 
handled the diagnosis of diffuse large B-cell lymphoma 
(DLBCL) (Figure 2).
Thoracic and abdominal computed tomography 
ruled out lymph node involvement, except in the 
mediastinum where some lymph nodes measuring up 
to 1.0 cm were present. Spleen and liver were normal. 
Bone marrow biopsy showed normal cellularity and 
absence of lymphomatous invasion. Therefore clinically 
the patient was considered as Stage I. HAART was 
restarted and the patient was referred to the oncology 
center.
DISCUSSION
HIV infected patients are at increased risk of 
developing malignancies.1-3 Lymphoma is frequently 
observed among immunosuppressive diseases such as 
AIDS. They usually present with extranodal involvement 
with diffuse aggressive histology, B-cell lineage 
derivation (95% of cases), in association with EBV, 
clinically aggressive courses, involving younger patients 
and presenting in advanced stage at the time of 
diagnosis.4-6 Up to 80% of the HIV-associated NHL 
arise systemically.5,7
In the beginning of AIDS epidemics a dramatic 
increase in the incidence of Kaposi sarcoma (KS), non-
Hodgkin lymphoma (NHL) and cervical cancer was 
observed, therefore these tumors were classified as 
AIDS-defining cancers. Regarding the gastrointestinal 
(GI) involvement in the first decade of epidemics, 
Danzig et al. found 32% of GI neoplasia mainly 
represented by silent KS and symptomatic NHL.8 
Figure 1. Endoscopic view of the gastric antrum, showing in its posterior wall a well-delimitated ulcerated lesion, 
with elevated borders, granular and clean wound bed.
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With the advent of HAART the incidence of KS and 
NHL decreased, but they were replaced by other 
malignancies (non-defining AIDS tumors).9
The GI tract is the main site for extranodal AIDS-
related NHL localization followed by the central nervous 
system involvement.6,10 In this setting GI involvement 
can be primary or secondary; the latter taking part of 
a disseminated disease. Dawson’s criteria11 are used 
for the diagnosis definition of primary GI lymphoma, 
and include: 1 – absence of peripheral palpable 
lymph nodes; 2 – normal plain chest radiography; 
3 – normal white blood cell count; 4 – predominant 
lesion confined to the GI tract; 5 – absence of liver and 
spleen involvement; 6- absence of lymphadenopathy 
on computerized tomography; 7 – absence of bone 
marrow involvement. Another definition of primary GI 
NHL was stated by Lewin et al., which criteria require 
GI symptoms or predominant lesions confined to the 
GI tract.12,13 According to these authors, our patient 
fulfilled all the criteria for the diagnosis of primary 
gastric lymphoma.
GI primary lymphomas are rare, showing an 
incidence of 0,8-1,2 cases per 100.000 persons per 
year.12,14 This entity represents up to 1% to 4% of 
the tumors of small intestine, stomach and colon,10 
while the secondary involvement of GI occurs in up to 
10% of patients.15 The stomach is the most frequent 
involved organ with 68%-75% of cases, followed by 
small intestine (9%), ileocecal region (7%) and rectum 
(2%).12
Primary gastric lymphoma represents 3% of all 
gastric malignancies and 10% of all lymphomas.12 
HIV-associated NHLs are related to long-term severe 
immunosuppression, low CD4 count (generally less 
than 100 cells/mm3), high viral load, increased age and 
previous AIDS defining condition.6 Gastric lymphomas 
Figure 2. A - Photomicrography of gastric biopsy showing large lymphoid cells exhibiting prominent nucleoli and 
basophilic cytoplasm in a diffuse growing pattern. (H&E, 400x); B - Immunohistochemistry showing diffuse staining 
for CD20 (400x); C - Focal immunostaining for CD30 (1000x); D - High proliferation index (80-90%) as accessed by 
Ki67 (400x).
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are more frequent among males between 50 and 60 
years of age.12
Epigastric pain, nausea and/or vomiting, anorexia 
usually represents clinical features associated to gastric 
lymphoma, but weight loss, early satiety and occult 
gastrointestinal bleeding are also frequently present. B 
symptoms are present in 12% of cases. Symptoms may 
vary from days to years, until the diagnosis is achieved.12 
Diagnosis may be made by endoscopy and imaging 
work up, always confirmed by histological examination. 
On endoscopy, gastric lymphoma may appear as a 
polypoid lesion, tumoral mass, erythematous mucosa, 
nodules or gastric ulcer, like the presentation found 
in our patient.16-18 Our patient’s endoscopic lesion was 
very suspicious of malignancy, due to the infiltrated, 
elevated and well circumscribed border with a clean 
ulcer bed. Peptic ulcer is usually more shallow and 
recovered by fibrinous debris. Endoscopic ultrasound 
may be helpful in determining the depth of gastric 
wall invasion as well as the presence of perigastric 
lymphatic nodes.19 The endoscopic ultrasound does 
not have enough accuracy to differentiate benign from 
malignant involvement, however when associated with 
biopsy the accuracy raises to 90%.20
After making the diagnosis, staging constitutes 
the next step for treatment planning. The Lugano 
Staging System21 (Table 1) is a modification of the 
original Ann Arbor staging system designed for 
the staging of primary gastointestinal lymphomas. 
Following the Lugano criteria, our patient presented 
the stage I.
The majority of gastric lymphomas is represented by 
MALT lymphomas (38%-48%) and DLBCL (45%-59%); 
the remaining cases are mantle cell lymphoma (1%), 
follicular lymphoma (0.5%-2%) and peripheral T-cell 
lymphoma (1.5%-4%).4,12 However, among the 
HIV-infected patients, the histological distribution is 
somewhat different. In this setting Burkitt lymphoma 
and DLBCL are the most representative, followed by 
primary effusion lymphoma, plasmablastic lymphoma 
(normally confined to the oral cavity) and in a small 
number, the classic Hodgkin lymphomas.6,22,23
DLBCL is a heterogeneous group of tumors that 
are characterized by large B-cells exhibiting prominent 
nucleoli, basophilic cytoplasm, a diffuse growing 
pattern and high proliferation index. Involved lymph 
nodes lose their normal architecture by the invasive 
atypical lymphoid cells, which are large cells resembling 
centroblasts or immunoblasts.24 Immunohistochemistry 
is characterized by the expression of CD19, CD20, 
CD22 and CD79a, as well as CD45.25
The pathogenesis of HIV-related lymphomas 
is multifactorial, besides the inherent HIV-induced 
immunosuppression; chronic antigenic stimulation, 
genetic abnormalities, cytokine deregulation and the 
role of EBV as well as HHV-8 also take part.22,26-28
The differential diagnosis include infectious 
mononucleosis, melanoma, carcinomas, Burkitt 
lymphoma, and T-cell anaplastic lymphoma.29,30
Although primary gastric DLCL has, currently, 
a better prognosis31 with r ituximab added to 
cyclophosphamide, doxorubicin, vincristine and 
Table 1. Lugano Staging System21 – Staging of primary gastrointestinal lymphoma
Stage Extent of lymphoma
I Confined to GI tract (single primary, or multiple non-contiguous lesions)
II Extending into abdomen from primary GI site
II1 = local nodal involvement
II2 = distant nodal involvement
IIE Penetration of serosa to involve adjacent organ or tissues
Specify site of involvement, e.g. IIE (pancreas)
If both nodal involvement and involvement of adjacent organs, denote stage using both a subscript (1 or 2) and 
E, e.g. II1 E (pancreas)
IV Disseminated extra-nodal involvement or concomitant supra-diaphragmatic nodal involvement
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prednisone, or with surgery plus chemotherapy and 
radiotherapy,32 the prognosis of NHL in HIV-positive 
patients is not as much favorable. Rezende et al.,33 
studying 243 HIV-positive patients submitted to upper 
gastrointestinal endoscopy found 6 cases of primary 
gastric NHL which showed a median survival time after 
diagnosis of 185 days.
H IV- re l a t ed  p r ima r y  ga s t r i c  l ymphoma 
predominates in long-term infected male patients, 
what is observed in this report. Our case calls attention 
to the age of the patient, the early stage at diagnosis 
(since the majority of cases present in advanced stages) 
in the presence of a reasonable elevated count of 
CD4 and viral load of 163,597 copies, what is atypical 
according to the literature.
Due to the relative frequency of GI involvement by 
lymphomas in AIDS patients, we call attention to the 
suspicion for this diagnosis in every HIV/AIDS patient 
presenting some or all of the following symptoms: 
non-apparent cause for epigastric pain, weight loss, B 
symptoms and signs suggestive of GI bleeding. Despite 
the advances in diagnostic methods and therapeutics, 
the occurrence of GI NHL has been associated to a 
shorter survival of the HIV-positive patients.
REFERENCES
1. Levine AM. AIDS-related malignancies. Curr Opin Oncol. 
1994;6(5):489-91.http://dx.doi.org/10.1097/00001622-
199409000-00007. PMid:7827151
2. Burgi A, Brodine S, Wegner S, et al. Incidence and 
risk factors for the occurrence of non-AIDS-defining 
cancers among human immunodeficiency virus-infected 
individuals. Cancer. 2005;104(7):1505-11.http://dx.doi.
org/10.1002/cncr.21334. PMid:16104038
3. Coté TR, Biggar RJ, Rosenberg PS, et al, and the 
AIDS/Cancer Study Group. Non-Hodgkin’s lymphoma 
among people with AIDS: incidence, presentation and 
public health burden. Int J Cancer. 1997;73(5):645-50. 
PMid:9398040. 
4. Grabar S, Le Moing V, Goujard C, et al. Clinical 
outcome of patients with HIV-1 infection according to 
immunologic and virologic response after 6 months 
of highly active antiretroviral therapy. Ann Intern Med. 
2000;133(6):401-10.http://dx.doi.org/10.7326/0003-
4819-133-6-200009190-00007. PMid:10975957
5. Levine AM, Seneviratne L, Espina BM, et al. Evolving 
characteristics of AIDS-related lymphoma. Blood. 
2000;96(13):4084-90. PMid:11110677.
6. Heise W. GI-lymphomas in immunosuppressed 
patients (organ transplantation; HIV). Best Pract Res 
Clin Gastroenterol. 2010;24(1):57-69.http://dx.doi.
org/10.1016/j.bpg.2010.01.001. PMid:20206109
7. Carbone A. AIDS-related non-Hodgkin’s lymphomas: from 
pathology and molecular pathogenesis to treatment. Hum 
Pathol. 2002;33(4):392-404.http://dx.doi.org/10.1053/
hupa.2002.124723. PMid:12055673
8. Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal 
malignancy in patients with AIDS. Am J Gastroenterol. 
1991;86(6):715-8. PMid:2038993.
9. Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising 
challenge of non-AIDS-defining cancers in HIV-infected 
patients. Clin Infect Dis. 2012;55(9):1228-35.http://
dx.doi.org/10.1093/cid/cis613. PMid:22776851
10. Powitz F, Bogner JR, Sandor P, Zietz C, Goebel FD, Zoller 
WG. Gastrointestinal lymphomas in patients with AIDS. 
Z Gastroenterol. 1997;35(3):179-85. PMid:9106981.
11. Dawson IM, Cornes JS, Morson BC. Primary malignant 
lymphoid tumours of the intestinal tract. Report of 37 
cases with a study of factors influencing prognosis. Br 
J Surg. 1961;49(213):80-9.http://dx.doi.org/10.1002/
bjs.18004921319. PMid:13884035
12. Koch P, del Valle F, Berdel WE, et al, and the German 
Multicenter Study Group. Primary gastrointestinal 
non-Hodgkin’s lymphoma: I. Anatomic and histologic 
distribution, clinical features, and survival data of 371 
patients registered in the German Multicenter Study 
GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861-73. 
PMid:11559724.
13. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas 
of the gastrointest inal tract:  a study of 117 
cases presenting with gastrointestinal disease. 
Cance r.  1978 ; 42 ( 2 ) : 693 - 707 . h t tp : / / d x .do i .
org/10.1002/1097-0142(197808)42:2<693::AID-
CNCR2820420241>3.0.CO;2-J. PMid:354774
14. Ducreux M, Boutron MC, Piard F, Carli PM, Faivre J. A 15-year 
series of gastrointestinal non-Hodgkin’s lymphomas: a 
population-based study. Br J Cancer. 1998;77(3):511-4.
http://dx.doi.org/10.1038/bjc.1998.82. PMid:9472653
15. Ehrlich AN, Stalder G, Geller W, Sherlock P. Gastrointestinal 
manifestations of malignant lymphoma. Gastroenterology. 
1968;54(6):1115-21. PMid:5656330.
16. Papaxoinis G, Papageorgiou S, Rontogianni D, et al. 
Primary gastrointestinal non-Hodgkin’s lymphoma: 
a clinicopathologic study of 128 cases in Greece. A 
Hellenic Cooperative Oncology Group study (HeCOG). 
Leuk Lymphoma. 2006;47(10):2140-6.http://dx.doi.
org/10.1080/10428190600709226. PMid:17071488
17. Spinelli P, Lo Gullo C, Pizzetti P. Endoscopic diagnosis of 
gastric lymphomas. Endoscopy. 1980;12(5):211-4.http://
dx.doi.org/10.1055/s-2007-1021745. PMid:7428725
Autopsy and Case Reports 2014; 4(2):49-54
Early stage primary gastric diffuse large B-cell lymphoma in a young HIV-positive patient
54
Conflict of interest: None
Submitted on: April 23, 2014
Accepted on: June 15, 2014
Correspondence 
Guilherme Harada 
Rua Augusta, 183, ap. 194, Bl. 3 – Vila Augusta – Guarulhos/SP – Brazil 
Cep 07025-130 
E-mail guiarada@hotmail.com
18. Loehr WJ, Mujahed Z, Zahn FD, Gray GF, Thorbjarnarson 
B. Primary lymphoma of the gastrointestinal tract: a 
review of 100 cases. Ann Surg. 1969;170(2):232-8.
http://dx.doi.org/10.1097/00000658-196908000-00011. 
PMid:5796708
19. Fischbach W, Goebeler-Kolve ME, Greiner A. Diagnostic 
accuracy of EUS in the local staging of primary gastric 
lymphoma: results of a prospective, multicenter study 
comparing EUS with histopathologic stage. Gastrointest 
Endosc. 2002;56(5):696-700.http://dx.doi.org/10.1016/
S0016-5107(02)70119-3. PMid:12397278
20. Harada N, Wiersema M, Wiersema L. Endosonography 
guided fine needle aspiration biopsy (EUS FNA) in the 
evaluation of lymphadenopathy: Staging accuracy 
of EUS FNA versus EUS alone. Gastrointest Endosc. 
1997;45(4):AB31. http://dx.doi.org/10.1016/S0016-
5107(97)80026-0.
21. Rohatiner A, d’Amore F, Coiffier B, et al. Report on a 
workshop convened to discuss the pathological and 
staging classifications of gastrointestinal tract lymphoma. 
Ann Oncol. 1994;5(5):397-400. PMid:8075046.
22. Bellan C, De Falco G, Lazzi S, Leoncini L. Pathologic aspects 
of AIDS malignancies. Oncogene. 2003;22(42):6639-
45.http: / /dx.doi .org/10.1038/s j .onc.1206815. 
PMid:14528289
23. Ho-Yen C, Chang F, van der Walt J, Lucas S. Gastrointestinal 
malignancies in HIV-infected or immunosuppressed 
patients: pathologic features and review of the literature. 
Adv Anat Pathol. 2007;14(6):431-43.http://dx.doi.
org/10.1097/PAP.0b013e31815946d9. PMid:18049132
24. De Paepe P, Achten R, Verhoef G, et al. Large 
cleaved and immunoblastic lymphoma may represent 
two distinct clinicopathologic entities within the 
group of diffuse large B-cell lymphomas. J Clin 
Oncol. 2005;23(28):7060-8.http://dx.doi.org/10.1200/
JCO.2005.15.503. PMid:16129841
25. Ottensmeier CH, Stevenson FK. Isotype switch variants 
reveal clonally related subpopulations in diffuse large B-cell 
lymphoma. Blood. 2000;96(7):2550-6. PMid:11001910.
26. Cinti C, Leoncini L, Nyongo A, et al. Genetic alterations 
of the retinoblastoma-related gene RB2/p130 identify 
different pathogenetic mechanisms in and among Burkitt’s 
lymphoma subtypes. Am J Pathol. 2000;156(3):751-60.
http://dx.doi.org/10.1016/S0002-9440(10)64941-3. 
PMid:10702389
27. Kramer MH, Hermans J, Wijburg E, et al. Clinical relevance 
of BCL2, BCL6, and MYC rearrangements in diffuse 
large B-cell lymphoma. Blood. 1998;92(9):3152-62. 
PMid:9787151.
28. Huang JZ, Sanger WG, Greiner TC, et al. The t(14;18) 
defines a unique subset of diffuse large B-cell lymphoma 
with a germinal center B-cell gene expression profile. 
Blood. 2002;99(7):2285-90.http://dx.doi.org/10.1182/
blood.V99.7.2285. PMid:11895757
29. Kitayama Y, Honda S, Sugimura H. Epstein-Barr virus-related 
gastric pseudolymphoma in infectious mononucleosis. 
Gastrointest Endosc. 2000;52(2):290-1.http://dx.doi.
org/10.1067/mge.2000.107715. PMid:10922116
30. Stein H, Warnke RA, Chan WC, Jaffe ES. Diffuse large 
B-cell lymphoma, not otherwise specified. In: Swerdlow 
S, Campo E, Harris NL, editors. International Agency 
for Research on Cancer. WHO classification of tumors 
of haematopoietic and lymphoid tissue. Genève: World 
Health Organization; 2008. p. 233-7.
31. Kobayashi Y, Hatta Y, Hojo A, et al. Long-term follow-up 
of localized, primary gastric diffuse large B-cell lymphoma 
treated with rituximab and CHOP. Exp Ther Med. 
2012;3(2):304-8. PMid:22969886.
32. Wu Y-X, Liu B, Chen L, Li JH, Chen SQ. Prognostic 
factors of primary gastric diffuse large B cell lymphoma: 
a retrospective study of 75 cases in China. Ann Hematol. 
2013;92(6):861-2.http://dx.doi.org/10.1007/s00277-
012-1646-4. PMid:23238898
33. Rezende REF, Mantelmacher M, Ferreira SC, et al. 
Clinical, endoscopic and prognostic aspects of primary 
gastric non-hodgkin’s lymphoma associated with 
acquired immunodeficiency syndrome. Braz J Infect 
Dis. 2009;13(1):2-4.http://dx.doi.org/10.1590/S1413-
86702009000100002. PMid:19578621
